Vasectomy Reversal Provides Symptomatic Relief in Patients With Postvasectomy Pain Syndrome: A Systematic Review

Postvasectomy pain syndrome (PVPS) is a poorly understood, chronic condition affecting up to 5% of men post vasectomy. With limited evidence guiding its management, vasectomy reversal (VR) has been referenced as a potential treatment modality. This systematic review evaluates the current literature on the efficacy of VR in relieving PVPS symptoms.

A systematic search was conducted across PubMed, ScienceDirect, SCOPUS, and Web of Science databases in accordance with Preferred Peporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Eligible studies included case series and clinical reports from the last 15 years that assessed pain outcomes after VR in men diagnosed with PVPS. Primary outcomes included pain resolution or reduction postoperatively, measured through visual analogue pain scores or patient-reported outcomes.

Five studies involving 123 patients were included, encompassing vasovasostomy, vasoepididymostomy, and robotic-assisted techniques. All studies reported symptomatic improvement after VR, with pain score reductions ranging from 60% to 83%. While 2 studies used validated pain scoring systems before intervention and post intervention, the remaining studies reported other subjective or percentage-based improvements. Across all studies, VR was associated with high rates of patient satisfaction and willingness to undergo the procedure again.

VR seems to offer meaningful pain relief in patients suffering from PVPS. However, further high-quality prospective studies and randomized controlled trials are needed to concretely establish its efficacy, compare it with alternative treatments, and develop standardized treatment algorithms.